Smartlab Exchange Europe

We are proud to announce that Dr Julien Marin, SVP, Chief Operating Officer, will be part of the Expert Speakers at Smartlab Exchange Europe 2026 in Amsterdam.

SmartLab Exchange Europe, as “the European Gathering for Lab Transformation Leaders”, brings together R&D leaders from sectors including pharma, biotech, F&B, chemicals, and FMCG to discuss practical approaches to modernising laboratory environments. Topics include integrating new and legacy systems, ensuring data integrity, and managing change to support adoption.

Sessions will cover how organisations are applying automation, AI, and analytics to improve efficiency, building interoperability across informatics platforms, and balancing innovation with compliance. The event offers cross-industry perspectives and real-world examples for labs at different stages of digitalisation.

Beyond Automation: Orchestration, Robots, and AI from Discovery to Production on Demand

Dr Julien Marin will hold a joint lecture with Anna Codina, Senior Director Strategy & Business Development at SciY on February 23 at 9:15 a.m.

Abstract: The pharmaceutical industry is accelerating toward an era of AI-augmented and self-driving laboratories, where human expertise is amplified by intelligent automation and data-driven orchestration. Yet the success of this transformation depends on a critical foundation: AI-ready, interoperable data.
In this joint presentation, SciY and Novalix share how digitalization platforms, automation, and applied AI are converging to reshape experimental design, process optimization, and manufacturing. Real-world examples, from reaction screening and structure verification to AI-piloted continuous manufacturing (PIPAc), will illustrate how FAIR data principles, semantic standardization, and orchestration across instruments, robotics, and enterprise systems unlock new levels of scientific efficiency and agility.

Key discussion points include:

• Designing a robust data strategy that bridges discovery, development, and manufacturing.
• Implementing closed-loop experimentation and real-time process optimization through intelligent orchestration layers.
• Demonstrating AI agents trained in digital twins to autonomously adjust reaction conditions for yield and safety.
• Empowering scientists as AI-augmented decision-makers in a connected ecosystem spanning CROs, CDMOs, and internal labs.

Join us during the event: Discover how Novalix can support your projects in drug discovery thanks to the combination of disciplines, expertise and techniques in dedicated platforms.